Zulma Yunt is a Respiratory physician affiliated with National Jewish Health. OpenAlex indexes 26 publications with 1,695 citations (h-index 10).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
1400 Jackson St
Denver, CO 802062761
Telephone
303-388-4461Provider last certified this registry record 17 Mar 2021.
Industry payments
5 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Boehringer Ingelheim Pharmaceuticals, Inc.Program year202523 payments$22,282openpaymentsdata.cms.gov ↗
- United Therapeutics CorporationProgram year20251 payment
- Boehringer Ingelheim Pharmaceuticals, Inc.Program year20245 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Respiratory
50.5%Corticosteroid36.4%Trelegy Ellipta45%Symbicort23%Breo Ellipta18%Fluticasone Propionate6%Arnuity Ellipta4%Qvar Redihaler4%Part D<11 patientsbeta2-Adrenergic Agonist9.1%Albuterol Sulfate Hfa100%Part D≥35 patients+ 3 more classes in this area
Cancer & immunology
24%Kinase inhibitor17%Ofev100%Part D≥17 patientsPyridone6.9%Pirfenidone100%Part D≥12 patientsMetabolism & gastrointestinal
16.1%Corticosteroid7.9%Prednisone100%Part D≥37 patientsH2 blocker5.7%Famotidine100%Part D≥19 patients+ 1 more class in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- One-Year Change in Quantitative Computed Tomography Is Associated with Meaningful Outcomes in Fibrotic Lung Disease
American Journal of Respiratory and Critical Care Medicine
2025 - Deep Learning Identifies Patients at Risk of Rapid Radiologic Progression in Pulmonary Fibrosis
American Journal of Respiratory and Critical Care Medicine
2025 - Peridiaphragmatic inflammation and fibrosis in myositis associated interstitial lung disease; a case series
Respiratory Medicine and Research
2025
Similar KOLs
Other experts from the same institution or the same specialty.
James Crapo, MD
National Jewish Health
Barry Make, MD
National Jewish Health
Jeffrey Swigris, DO
National Jewish Health
Michael Wechsler, MD
National Jewish Health
Fernando Martinez, MD
University of Massachusetts Chan Medical School
David Gozal, MD
Marshall University
Ronald Crystal, MD
Weill Cornell Medicine
Bartolome Celli, MD
Brigham and Women's Hospital
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”